53 With GLP1-ELP opt treatment, there is a clear trend of decreased weight loss with increasing severity of disease phenotype, from leptin resistant DIO mice 54 , to Lep ob/ob and LepR db/db mice.
← all excerpts
One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer.
1
—
—